Treatment of hepatic encephalopathy.
نویسنده
چکیده
The mortality of coma complicating acute hepatic necrosis remains high at about 80% and recently exchange transfusion has shown some promising results. This line of treatment is based on the assumption that improvement depends on the removal of non-dialysable toxic substances from the circulation although some authors have suggested that the benefit might be due to the addition of deficient factors such as antibody (Morris, Gocke & Sardi, 1967). In fact the first successful treatment of hepatic coma by exchange transfusion was more than 10 years ago (Lee & Tink, 1958) but there has been a resurgence in interest in this therapy following the complete recovery of six patients out of eleven treated by Trey, Burns & Saunders (1966). Other workers have failed to achieve such good results (Jones et al., 1967) but the relative simplicity of the method and the high mortality of coma in acute necrosis would seem to indicate its use in patients not responding to conventional measures of protein restriction and gut sterilization. The majority of reports indicate that exchange of at least one blood-volume must be carried out for appreciable clinical improvement to occur and this must be repeated on subsequent days. Whenever possible fresh citrated blood should be used but exchange transfusion may be complicated by coagulation defects due to both the hepatitis and the actual blood exchange itself (Samson et al., 1967). The same authors have discussed the importance of hypoglycaemia which may also extend the hazards of exchange transfusion in hepatic necrosis. We have had the opportunity of treating five patients with exchange transfusion (Table 1). Three of these patients had coma complicating acute hepatic necrosis and two had very severe portosystemic encephalopathy complicating cirrhosis. In retrospect the volumes of blood exchanged may have been too small and the procedure performed too late. The technical difficulties of obtaining fresh matched blood may be avoided by plasma-exchange which has been exploited by Sabin & Merritt (1968). They removed the patient's plasma and returned the patient's packed red cells and fresh frozen donor plasma. Encouraging results were obtained in these patients with cirrhosis and refractory coma. Further methods of treatment are at present being examined but, as yet, it is too early to assess their effectiveness. Burnell et al. (1967) have performed cross circulation exchanges with some success, but with this method there are ethical difficulties in the choice of suitable partners and practical problems with donor reactions. Extra-corporeal circulation of patients' blood through an isolated perfused cadaveric liver (Sen et al., 1966) and heterologous perfusion using pig's liver (Eisman, Liem & Raffucci, 1965) may produce some neurological improvement, but such measures require extensive facilities and have not been used in this country.
منابع مشابه
Evaluation of the role of TLR4 in endotoxin-induced hepatic encephalopathy in rats with biliary cirrhosis
Background: Hepatic encephalopathy is defined as a neuropsychiatric brain dysfunction in acute or chronic liver failure. Infection and inflammation have crucial role in its pathophysiology. The purpose of our study was to demonstrate the relationship between toll-like receptor 4 (TLR4) expression and the encephalopathy induced with endotoxin in biliary cirrhotic rats. Methods: The present stud...
متن کاملRifaximin in the treatment of hepatic encephalopathy
Hepatic encephalopathy is a challenging complication in patients with advanced liver disease. It can be defined as a neuropsychiatric syndrome caused by portosystemic venous shunting, ranging from minimal to overt hepatic encephalopathy or coma. Its pathophysiology is still unclear, although increased levels of ammonia play a key role. Diagnosis of hepatic encephalopathy is currently based on s...
متن کاملRifaximin treatment in hepatic encephalopathy.
BACKGROUND Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for prevention of the disease has not been established. METHODS In this randomized, double-blind, placebo-controlled trial, we randomly assigned 299 p...
متن کاملEvaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
Hepatic encephalopathy is a spectrum of neurocognitive manifestations often seen in patients with liver injury or rarely in patients with portosystemic shunting without liver injury. It can be divided into minimal (covert) hepatic encephalopathy and overt hepatic encephalopathy, depending on the severity. Patients with hepatic encephalopathy have compromised clinical outcomes, decreased quality...
متن کاملComparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
INTRODUCTION Hepatic encephalopathy is challenging complication of liver dysfunction. Therapeutic treatment options for hepatic encephalopathy are currently limited and have appreciable risks and benefits associated with their use. Rifaximin is a novel anti microbiological agent with wide spectrum of activity that has shown promise as an alternative option for hepatic encephalopathy. AIMS AND...
متن کاملDiagnosis and treatment of hepatic encephalopathy.
Hepatic encephalopathy arises from the combination of hepatocellular dysfunction and portal-systemic shunting. Encephalopathy is more prominent in advanced stages of liver cirrhosis and signals the presence of fulminant hepatic failure in patients with acute liver injury. As important as the extent of shunting is the presence of large spontaneous collaterals. Ammonia continues to be a leading t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Postgraduate medical journal
دوره 45 521 شماره
صفحات -
تاریخ انتشار 1969